Product Information
LISDEXAMFETAMINE 60 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.9745 per EA under NDC 00480357001. Its NADAC has been published 75 times since Jan 22, 2025.
Strength
60 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480357001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202802On Market Since
12/17/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has been published 75 times since Jan 22, 2025, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9745 per EA |
|---|---|
| All-time high | $5.5994 (Feb 12, 2025) |
| All-time low | $2.9295 (Mar 18, 2026) |
| 52-week high | $4.4733 |
| 52-week low | $2.9295 |
| Median price | $3.3750 |
| Average price | $3.8152 |
| Largest weekly change | -12.6% (Jul 23, 2025) |
| Weeks tracked | 75 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 60 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.9745 per EA (NDC 00480357001), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has declined 46.9%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 60 MG CAPSULE?
Since Jan 22, 2025, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has ranged from a low of $2.9295 (Mar 18, 2026) to a high of $5.5994 (Feb 12, 2025), with a median of $3.3750 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 60 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 60 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 60 MG CAPSULE?
LISDEXAMFETAMINE 60 MG CAPSULE (NDC 00480357001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification